Citations

Clear

3314 citation(s) found for "Yu, Alexander".

Feasibility of achieving planned surgical margins in primary spine tumor: a PTRON study
Dandurand, Charlotte , Fisher, Charles G. , Rhines, Laurence D. , Charest-Morin, Raphaële , Luzzati, Alessandro , Reynolds, Jeremy , Wei, Feng , Gokaslan, Ziya L. , Sciubba, Daniel M. , Lazáry, Áron , Kawahara, Norio , Rampersaud, Y. Raja , Disch, Alexander C. , Chou, Dean , Hornicek, Francis J. , Laufer, IIya, Sahgal, Arjun , Dea, Nicolas , Reynolds, Jeremy , Reynolds, Jeremy , Lazary, Aron , Boriani, Stefano , Gasbarrini, Alessandro , Bettegowda, Chetan , Clarke, Michelle J. , Shin, John H.

Mayo Clinic

Neurosurgical Focus | May 1, 2021 | Volume: 50 | Issue: 5 | Pages: E16

10.3171/2021.2.focus201091 | PMID 33932923 Get It

OBJECTIVE Oncological resection of primary spine tumors is associated with lower recurrence rates. However, even in the most experienced hands, the execution of a meticulously drafted plan sometimes fails. The objectives of this study were to determine how successful surgical teams are at achieving planned surgical margins and how successful surgeons are in intraoperatively assessing tumor margins. The secondary objective was to identify factors associated with successful execution of planned resection. METHODS The Primary Tumor Research and Outcomes Network (PTRON) is a multicenter international prospective registry for the management of primary tumors of the spine. Using this registry, the authors compared 1) the planned surgical margin and 2) the intraoperative assessment of the margin by the surgeon with the postoperative assessment of the margin by the pathologist. Univariate analysis was used to assess whether factors such as histology, size, location, previous radiotherapy, and revision surgery were associated with successful execution of the planned margins. RESULTS Three hundred patients were included. The surgical plan was successfully achieved in 224 (74.7%) patients. The surgeon correctly assessed the intraoperative margins, as reported in the final assessment by the pathologist, in 239 (79.7%) patients. On univariate analysis, no factor had a statistically significant influence on successful achievement of planned margins. CONCLUSIONS In high-volume cancer centers around the world, planned surgical margins can be achieved in approximately 75% of cases. The morbidity of the proposed intervention must be balanced with the expected success rate in order to optimize patient management and surgical decision-making.
Practical development and operationalization of a 12-hour hospital census prediction algorithm
Ryu, Alexander J. , Romero‐Brufau, Santiago , Shahraki, Narges, Zhang, Jiawei , Qian, Ray , Kingsley, Thomas C. , Romero-Brufau, Santiago , Ryu, Alexander J.

Mayo Clinic

Journal of the American Medical Informatics Association | April 30, 2021 | Volume: 28 | Issue: 9 | Pages: 1977-1981

10.1093/jamia/ocab089 | PMID 34151986 Get It

Abstract Hospital census prediction has well-described implications for efficient hospital resource utilization, and recent issues with hospital crowding due to CoVID-19 have emphasized the importance of this task. Our team has been leading an institutional effort to develop machine-learning models that can predict hospital census 12 hours into the future. We describe our efforts at developing accurate empirical models for this task. Ultimately, with limited resources and time, we were able to develop simple yet useful models for 12-hour census prediction and design a dashboard application to display this output to our hospital’s decision-makers. Specifically, we found that linear models with ElasticNet regularization performed well for this task with relative 95% error of +/− 3.4% and that this work could be completed in approximately 7 months.
Validation of CP‐GEP (Merlin Assay) for predicting sentinel lymph node metastasis in primary cutaneous melanoma patients: A U.S. cohort study
Yousaf, Ahmed , Tjien-Fooh, Félicia , Rentroia‐Pacheco, Barbara , Quattrocchi, Enrica , Kobic, Ajdin, Tempel, Dennie , Meves, Alexander , Meves, Alexander , Kolodney, Michael S.

Mayo Clinic

International Journal of Dermatology | April 29, 2021 | Volume: 60 | Issue: 7 | Pages: 851-856

10.1111/ijd.15594 | PMID 33914348 Get It

AbstractBackgroundApproximately 85% of melanoma patients who undergo a sentinel lymph node biopsy (SLNB) are node‐negative. Melanoma incidence is highest in patients ≥65 years, but their SLNB positivity rate is lower than in younger patients. CP‐GEP, a model combining clinicopathologic and gene expression variables, identifies primary cutaneous melanoma (CM) patients who may safely forgo SLNB due to their low risk for nodal metastasis. Here, we validate CP‐GEP in a U.S. melanoma patient cohort.MethodsA cohort of 208 adult patients with primary CM from the Mayo Clinic and West Virginia University was used. Patients were stratified according to their risk for nodal metastasis: CP‐GEP High Risk and CP‐GEP Low Risk. The main performance measures were SLNB reduction rate (RR) and negative predictive value (NPV).ResultsSLNB positivity rate for the entire cohort was 21%. Most patients had a T1b (34%) or T2a (31%) melanoma. In the T1‐T2 group (153 patients), CP‐GEP achieved an SLNB RR of 41.8% (95% CI: 33.9‐50.1) at an NPV of 93.8% (95% CI: 84.8‐98.3). Subgroup analysis showed similar performance in T1‐T2 patients ≥65 years of age (51 patients; SLNB positivity rate, 9.8%): SLNB RR of 43.1% (95% CI: 29.3‐57.8) at an NPV of 95.5% (95% CI: 77.2‐99.9).ConclusionWe confirmed the potential of CP‐GEP to reduce negative SLNB in all relevant age groups. Our findings are especially relevant to patients ≥65 years, where surgery is often elective. CP‐GEP may guide SLNB decision‐making in clinical practice.
Combined local delivery of tacrolimus and stem cells in hydrogel for enhancing peripheral nerve regeneration
Saffari, Tiam M. , Chan, Katelyn, Saffari, Sara , Zuo, Kevin J. , McGovern, Renee M., Shin, Alexander Y. , Chan, K. Ming , Reid, Joel M. , Shin, Alexander Y , Chan, Katelyn, Borschel, Gregory Howard

Mayo Clinic

Biotechnology and Bioengineering | April 29, 2021 | Volume: 118 | Issue: 7 | Pages: 2804-2814

10.1002/bit.27799 | PMID 33913523 Get It

AbstractThe application of scaffold‐based stem cell transplantation to enhance peripheral nerve regeneration has great potential. Recently, the neuroregenerative potential of tacrolimus (a U.S. Food and Drug Administration‐approved immunosuppressant) has been explored. In this study, a fibrin gel‐based drug delivery system for sustained and localized tacrolimus release was combined with rat adipose‐derived mesenchymal stem cells (MSC) to investigate cell viability in vitro. Tacrolimus was encapsulated in poly(lactic‐co‐glycolic) acid (PLGA) microspheres and suspended in fibrin hydrogel, using concentrations of 0.01 and 100 ng/ml. Drug release over time was measured. MSCs were cultured in drug‐released media collected at various days to mimic systemic exposure. MSCs were combined with (i) hydrogel only, (ii) empty PLGA microspheres in the hydrogel, (iii) 0.01, and (iv) 100 ng/ml of tacrolimus PLGA microspheres in the hydrogel. Stem cell presence and viability were evaluated. A sustained release of 100 ng/ml tacrolimus microspheres was observed for up to 35 days. Stem cell presence was confirmed and cell viability was observed up to 7 days, with no significant differences between groups. This study suggests that combined delivery of 100 ng/ml tacrolimus and MSCs in fibrin hydrogel does not result in cytotoxic effects and could be used to enhance peripheral nerve regeneration.
System of Psychological Support Based on Positive Suggestions to the Critically Ill Using ICU Doulas
Karnatovskaia, Lioudmila V. , Schultz, Jason, Steele, Amanda J., Baker, Brittany A., Philbrick, Kemuel L. , Valle, Kathryn T. del , Johnson, Kimberly R. , Gajić, Ognjen, Varga, Katalin , Schultz, Jason M, Del Valle, Kathryn T, Del Valle, Kathryn T , Niven, Alexander S. , Baker, Brittany A., Gajic, Ognjen

Mayo Clinic

Critical Care Explorations | April 27, 2021 | Volume: 3 | Issue: 4 | Pages: e0403

10.1097/cce.0000000000000403 | PMID 33912833 Get It

Background: Surviving critical illness often creates a lasting psychological impact, including depression, anxiety, and post-traumatic stress. Memories of frightening and delusional experiences are the largest potentially modifiable risk factor, but currently, there is no proven intervention to improve these inciting factors. Psychological support based on positive suggestion is a psychotherapeutic approach that can be provided even to patients in altered cognitive states and is therefore a viable psychotherapy intervention throughout the ICU stay. Traditional ICU care team members have limited time and training to provide such psychological support to patients. Doulas are trained supportive companions who have been effectively used to provide patient advocacy and emotional support in other clinical settings and may address this need. Our aim was to train and implement a psychological support based on positive suggestion program for the critically ill using doulas, and measure acceptance of this intervention through stakeholder feedback. Methods: Doula training included three objectives: an introduction to ICU practice structure and policies; education about fundamental aspects of critical care conditions and procedures; and didactic and hands-on learning experiences in effective use of psychological support based on positive suggestion in the critically ill. Doulas were evaluated at the end of their training and during subsequent clinical activities using competency-based assessments as well as through survey-based questions and interviews with key stakeholders. Results: The ICU doulas performed psychological support based on positive suggestion on 43 critically ill patients in the ICU setting. Stakeholder feedback from nurses, patients, and patient families was positive. The majority (28/32) of surveyed bedside ICU nurses reported that the doulas’ involvement was helpful for both patients and nurses alike. All interviewed family members offered positive comments about the ICU doula presence and of the 40 patients who recalled the intervention 37 found it comforting. Conclusions: Our program successfully trained two doulas to work effectively in the ICU setting performing patient-centered psychological support based on positive suggestion interventions. Their training improved their skill sets and was reported as beneficial by patients, families, and critical care nursing. This training program offers a proof of concept that could be applied in other medical centers, bringing doulas more commonly into the ICU practice to help humanize the experience for patients, families, and medical teams.
MacroH2A histone variants modulate enhancer activity to repress oncogenic programs and cellular reprogramming
Kaur, Jagneet, Moore-Weiss, John, Shimp, Lynzie, Nagi, Chandandeep , Carcamo, Saul , Chung, Chi‐Yeh, Hasson, Dan , Revzin, Alexander , Ördög, Tamás , Bernstein, Emily , Ismail, Wazim Mohammed , Mazzone, Amelia , Safgren, Stephanie L. , Buciuc, Marina , Duarte, Luis, Dadgar, Neda , Zhong, Jian , Lee, Jeong‐Heon , Gaspar‐Maia, Alexandre

Mayo Clinic

No container title available | April 26, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-384560/v1 Get It

Abstract Considerable efforts have been made to characterize active enhancer elements, which can be annotated by accessible chromatin and H3 lysine 27 acetylation (H3K27ac). However, apart from poised enhancers that are observed in early stages of development and putative silencers, the functional significance of cis-regulatory elements lacking H3K27ac is poorly understood. Here we show that macroH2A histone variants mark a subset of enhancers in normal and cancer cells, which we coined ‘macroH2A-Bound Enhancers’, that negatively modulate enhancer activity. We find macroH2A variants enriched at enhancer elements that are devoid of H3K27ac in a cell type-specific manner, indicating a role for macroH2A at inactive enhancers to maintain cell identity. In following, reactivation of macro-bound enhancers is associated with oncogenic programs in breast cancer and its repressive role is correlated with the activity of macroH2A2 as a negative regulator of BRD4 chromatin occupancy. Finally, through single cell epigenomic profiling, we show that the loss of macroH2A2 leads to increased cellular heterogeneity that may help to explain the role of macroH2A variants in defining oncogenic transcriptional dependencies.
British Society of Gastroenterology guidelines on the management of irritable bowel syndrome
Vasant, Dipesh H. , Paine, Peter , Black, Christopher J. , Houghton, Lesley A. , Everitt, Hazel , Corsetti, Maura , Aziz, Imran , Farmer, Adam D. , Eugenicos, Maria , Moss‐Morris, Rona , Yiannakou, Yan , Ford, Alexander C. , Aziz, Imran , Ford, Alexander C , Houghton, L A , Corsetti, M , Black, Christopher J , Vasant, Dipesh H , Farmer, Adam D , Agrawal, Anurag

Mayo Clinic

Gut | April 26, 2021 | Volume: 70 | Issue: 7 | Pages: 1214-1240

10.1136/gutjnl-2021-324598 | PMID 33903147 Get It

Irritable bowel syndrome (IBS) remains one of the most common gastrointestinal disorders seen by clinicians in both primary and secondary care. Since publication of the last British Society of Gastroenterology (BSG) guideline in 2007, substantial advances have been made in understanding its complex pathophysiology, resulting in its re-classification as a disorder of gut-brain interaction, rather than a functional gastrointestinal disorder. Moreover, there has been a considerable amount of new evidence published concerning the diagnosis, investigation and management of IBS. The primary aim of this guideline, commissioned by the BSG, is to review and summarise the current evidence to inform and guide clinical practice, by providing a practical framework for evidence-based management of patients. One of the strengths of this guideline is that the recommendations for treatment are based on evidence derived from a comprehensive search of the medical literature, which was used to inform an update of a series of trial-based and network meta-analyses assessing the efficacy of dietary, pharmacological and psychological therapies in treating IBS. Specific recommendations have been made according to the Grading of Recommendations Assessment, Development and Evaluation system, summarising both the strength of the recommendations and the overall quality of evidence. Finally, this guideline identifies novel treatments that are in development, as well as highlighting areas of unmet need for future research.
A Novel Approach to Improve Newborn Screening for Congenital Hypothyroidism by Integrating Covariate-Adjusted Results of Different Tests into CLIR Customized Interpretive Tools
Rowe, Alexander D. , Stoway, Stephanie D., Åhlman, Henrik, Arora, Vaneet, Caggana, Michele, Fornari, Anna, Hagar, Arthur F. , Marquardt, Gregg, Miller, Bobby J., Nixon, Christopher, Norgan, Andrew P. , Orsini, Joseph J. , Pettersen, Rolf D. , Piazza, Amy L. , Schubauer, Neil R., Smith, Amy C., Tang, Hao , Wei, Sainan , Zetterström, Rolf , Currier, Robert J. , Mørkrid, Lars , Rinaldo, Piero, Hagar, Arthur , Marquardt, Gregg C, Zetterström, Rolf H , Currier, Robert , Norgan, Andrew P , Hall, Patricia , Tavakoli, Norma P.

Mayo Clinic

International Journal of Neonatal Screening | April 25, 2021 | Volume: 7 | Issue: 2 | Pages: 23

10.3390/ijns7020023 | PMID 33922835 Get It

Newborn screening for congenital hypothyroidism remains challenging decades after broad implementation worldwide. Testing protocols are not uniform in terms of targets (TSH and/or T4) and protocols (parallel vs. sequential testing; one or two specimen collection times), and specificity (with or without collection of a second specimen) is overall poor. The purpose of this retrospective study is to investigate the potential impact of multivariate pattern recognition software (CLIR) to improve the post-analytical interpretation of screening results. Seven programs contributed reference data (N = 1,970,536) and two sets of true (TP, N = 1369 combined) and false (FP, N = 15,201) positive cases for validation and verification purposes, respectively. Data were adjusted for age at collection, birth weight, and location using polynomial regression models of the fifth degree to create three-dimensional regression surfaces. Customized Single Condition Tools and Dual Scatter Plots were created using CLIR to optimize the differential diagnosis between TP and FP cases in the validation set. Verification testing correctly identified 446/454 (98%) of the TP cases, and could have prevented 1931/5447 (35%) of the FP cases, with variable impact among locations (range 4% to 50%). CLIR tools either as made here or preferably standardized to the recommended uniform screening panel could improve performance of newborn screening for congenital hypothyroidism.
Shared Decision Making Tools for People Facing Stroke Prevention Strategies in Atrial Fibrillation: A Systematic Review and Environmental Scan
Roldan, Victor D. Torres , McCarthy, Sarah , Ponce, Oscar J. , Belluzzo, Tereza , Urtecho, Meritxell , Suárez, Nataly R. Espinoza , Toloza, Freddy J.K. , Thota, Anjali, Organick, Paige, Liu-Sanchez, Carolina , Jaladi, Soumya , Hargraves, Ian , Brito, Juan P. , McCarthy, Sarah R. , Torres Roldan, Victor D , Brand-McCarthy, Sarah R, Espinoza Suarez, Nataly R , Thota, Anjali D, Organick, Paige W, Barrera, Francisco, Ozanne, Elissa M , Hargraves, Ian G, Montori, Victor M , McCarthy, Sarah R , Liu-Sanchez, Carolina , Brito, Juan P , Ponce, Oscar Josue , Barrera, Francisco J. , Prokop, Larry J. , Ozanne, Elissa M. , Fagerlin, Angela , Noseworthy, Peter A. , Montori, Víctor M. , McCarthy, Sarah R.

Mayo Clinic

Medical Decision Making | April 24, 2021 | Volume: 41 | Issue: 5 | Pages: 540-549

10.1177/0272989x211005655 | PMID 33896270 Get It

Objective Shared decision making (SDM) tools can help implement guideline recommendations for patients with atrial fibrillation (AF) considering stroke prevention strategies. We sought to characterize all available SDM tools for this purpose and examine their quality and clinical impact. Methods We searched through multiple bibliographic databases, social media, and an SDM tool repository from inception to May 2020 and contacted authors of identified SDM tools. Eligible tools had to offer information about warfarin and ≥1 direct oral anticoagulant. We extracted tool characteristics, assessed their adherence to the International Patient Decision Aids Standards, and obtained information about their efficacy in promoting SDM. Results We found 14 SDM tools. Most tools provided up-to-date information about the options, but very few included practical considerations (e.g., out-of-pocket cost). Five of these SDM tools, all used by patients prior to the encounter, were tested in trials at high risk of bias and were found to produce small improvements in patient knowledge and reductions in decisional conflict. Conclusion Several SDM tools for stroke prevention in AF are available, but whether they promote high-quality SDM is yet to be known. The implementation of guidelines for SDM in this context requires user-centered development and evaluation of SDM tools that can effectively promote high-quality SDM and improve stroke prevention in patients with AF.
Genome-wide analysis of 944 133 individuals provides insights into the etiology of haemorrhoidal disease
Zheng, Tenghao , Ellinghaus, David , Juzėnas, Simonas , Cossais, François , Burmeister, Greta , Mayr, Gabriele , Jørgensen, Isabella Friis , Teder‐Laving, Maris , Skogholt, Anne Heidi , Chen, Sisi , Strege, Peter R. , Ito, Go , Banasik, Karina , Bokelmann, Frank, Buch, Stephan , Clausnitzer, Hartmut, Degenhardt, Frauke , Doniec, Marek J., Erikstrup, Christian , Förster, Michael , Frey, Norbert , Fritsche, Lars G. , Gabrielsen, Maiken E. , Gräßle, Tobias , Gsur, Andrea , Hampe, Jochen , Hendricks, Alexander , Hinz, Sebastian , Jongen, Johannes , Junker, Ralf, Karlsen, Tom H. , Hemmrich‐Stanisak, Georg , Kruis, Wolfgang , Kupčinskas, Juozas , Laubert, Tilman , Rosenstiel, Philip , Röcken, Christoph , Laudes, Matthias , Leendertz, Fabian H. , Limperger, Verena , Margetis, Nikolaos, Mätz‐Rensing, Kerstin, Németh, Christopher Georg , Ness‐Jensen, Eivind , Nowak‐Göttl, Ulrike, Pandit, Anita , Pedersen, Ole Birger , Peleikis, H.-G., Peuker, Kenneth , Rodríguez, Cristina Leal , Schniewind, Bodo, Schulzky, Martin, Skiecevičienė, Jurgita , Tepel, Jürgen, Thomas, Laurent F. , Uellendahl-Werth, Florian , Ullum, Henrik , Vogel, Ilka, Völzke, Henry , Schönfels, Witigo von , Vanderwerff, Brett , Wilking, Julia, Wittig, Michael , Zeißig, Sebastian , Zobel, Myrko, Zawistowski, Matthew , Vacic, Vladimir, Sazonova, Olga V. , Noblin, Elizabeth S., Farrugia, Gianrico , Kahlke, Volker, Schafmayer, Clemens , D’Amato, Mauro , Datz, Christian , Forster, Michael , Gsur, Andrea , Hampe, Jochen , Röcken, Christoph , Ness-Jensen, Eivind , Rühlemann, Malte Christoph , Farrugia, Gianrico , D'Amato, Mauro , Franke, André , Ellinghaus, David , Zheng, Tenghao , Strege, Peter R , Erikstrup, Christian , Kupcinskas, Juozas , Becker, Thomas S , Brunak, Søren , Esko, Tõnu , Groß, Justus , Hveem, Kristian , Lieb, Wolfgang , Fersen, Lorenzo von , Sazonova, Olga, Beyder, Arthur , Wedel, Thilo

Mayo Clinic

Gut | April 22, 2021 | Volume: 70 | Issue: 8 | Pages: 1538-1549

10.1136/gutjnl-2020-323868 | PMID 33888516 Get It

Objective Haemorrhoidal disease (HEM) affects a large and silently suffering fraction of the population but its aetiology, including suspected genetic predisposition, is poorly understood. We report the first genome-wide association study (GWAS) meta-analysis to identify genetic risk factors for HEM to date. Design We conducted a GWAS meta-analysis of 218 920 patients with HEM and 725 213 controls of European ancestry. Using GWAS summary statistics, we performed multiple genetic correlation analyses between HEM and other traits as well as calculated HEM polygenic risk scores (PRS) and evaluated their translational potential in independent datasets. Using functional annotation of GWAS results, we identified HEM candidate genes, which differential expression and coexpression in HEM tissues were evaluated employing RNA-seq analyses. The localisation of expressed proteins at selected loci was investigated by immunohistochemistry. Results We demonstrate modest heritability and genetic correlation of HEM with several other diseases from the GI, neuroaffective and cardiovascular domains. HEM PRS validated in 180 435 individuals from independent datasets allowed the identification of those at risk and correlated with younger age of onset and recurrent surgery. We identified 102 independent HEM risk loci harbouring genes whose expression is enriched in blood vessels and GI tissues, and in pathways associated with smooth muscles, epithelial and endothelial development and morphogenesis. Network transcriptomic analyses highlighted HEM gene coexpression modules that are relevant to the development and integrity of the musculoskeletal and epidermal systems, and the organisation of the extracellular matrix. Conclusion HEM has a genetic component that predisposes to smooth muscle, epithelial and connective tissue dysfunction.